C.D.C. Panel Recommends a New Shingles Vaccine

C.D.C. Panel Recommends a New Shingles Vaccine

https://www.doximity.com/doc_news/v2/entries/9847908

WASHINGTON — In an unusually close vote, an advisory panel to the Centers for Disease Control and Prevention on Wednesday recommended the use of a new vaccine to prevent shingles over an older one that was considered less effective.

The decision was made just days after the Food and Drug Administration announced approval of the new vaccine, called Shingrix and manufactured by GlaxoSmithKline, for adults aged 50 and older. The panel’s recommendation gives preference to the new vaccine over Merck’s Zostavax, which has been the only shingles vaccine on the market for over a decade and was recommended for people aged 60 and older.

The panel also recommended that adults who have received the older vaccine get the new one.

According to the C.D.C., almost 1 of every 3 people in the United States will contract shingles,

a viral infection that can result in a painful rash and lasting nerve damage.

The disease, also known as herpes zoster, can range in severity from barely noticeable to debilitating. It is caused by the varicella-zoster virus, which also triggers chickenpox.

Patient and Advocate Yanekah, Masters in Critical Disabiities, shares an intimate journal moment in a busy, pained Mommy day.

An inspiring, intimate journal sharing of what it is to be a CHRONIC PAIN mommie.

 

“Opioids: The Next Tobacco?”

Don’t let opportunistic trial lawyers get rich off opioid crisis

http://thehill.com/opinion/healthcare/357610-dont-let-opportunistic-trial-lawyers-get-rich-off-opioid-crisis

President Trump has now declared the nation’s opioid crisis a “public health emergency.” This important step follows the recommendation by a White House commission, led by New Jersey Governor Chris Christie, to “act boldly,” to stem the crisis.  

As this epidemic of drug abuse becomes a growing problem for many states across the country, details of a White House strategy remain unclear. But as a recent Wall Street Journal editorial noted, the “horrors of opioid addiction come from many dysfunctions, including too many prescriptions, a decline in work, heroin and fentanyl, easy access from Medicaid, and others.”

Understandably then, as reported by a joint task force of the National Association of Counties and the National League of Cities, many communities are already cooperatively bringing together health care professionals, drug makers and distributors, regulators, law enforcement officials and social service providers “to break the cycles of addiction, overdose, and death” as they work through “partnerships across … local, state and federal levels.”

But having let themselves be convinced that communities can somehow sue their way out of complex opioid abuse problems, some state and local prosecutors have taken a more adversarial approach. Not coincidentally, those doing the convincing are many of the same private-sector personal injury lawyers who got rich beyond their wildest dreams with contingency fees two decades ago when they convinced state attorneys general to let them run lawsuits against cigarette makers.

So no one should be surprised that the personal injury lawyers’ national trade group here in Washington hosted in September a “Rapid Response: Opioid Litigation Seminar” to teach attendees how they too might cash in on such litigation. One of the breakout sessions was even titled, “Opioids: The Next Tobacco?”

Never mind that prescription opioid pain-relievers are not like cigarettes. They were developed to address a legitimate medical need. They require Food and Drug Administration approval and stark warning labels about the potential for addiction, and their lawful distribution is closely regulated by the Drug Enforcement Administration. Of course, as we’ve all learned in recent years, what may begin with doctors’ thoughtful prescriptions of lawful medicines for patients’ terrible pain can in some cases end in the streets with overdoses on illegal and deadly drugs such as heroin and fentanyl.     

Not to be deterred by facts or nuance, much less the public interest, though, self-interested personal injury lawyers have talked a coalition of 41 state attorneys general into issuing subpoenas for five drug manufacturers that seek information about how prescription opioids were marketed and sold. Several state AGs have already gone further, filing multi-count lawsuits against drug makers and distributors, with dozens of county and city prosecutors following suit. And most of these prosecutors have hired private-sector lawyers to consult or run their lawsuits.  

The prosecutors assert that hiring outside counsel on a contingency-fee basis saves taxpayers money since counsel only gets paid if litigation is successful. This simple rationale, however, overlooks the conflicts of interest and corruption to which such arrangements have often led. A litany of these types of abuses has been chronicled for more than a decade by the Wall Street Journal’s editorial board and a Pulitzer Prize-winning New York Times series.

This reporting has revealed that politically influential plaintiffs’ lawyers frequently shop their ideas for potentially lucrative lawsuits against corporate defendants to friendly state prosecutors who then hire the lawyers, expecting generous pay-to-play campaign contributions later.

Thus the American Tort Reform Association (ATRA) urges all policymakers to insist that the public interest in health and safety is never compromised by private interests. This principle has animated ATRA’s efforts for more than a decade to push commonsense reform statutes — successfully in 18 states so far — that promote accountability and transparency when public authorities choose to hire outside counsel on a contingency-fee basis.

Too many Americans are suffering serious drug abuse problems, and our leaders must work together to find good-faith solutions. They ought to be relying for guidance on caring and knowledgeable experts inside and outside of government. Because to rely on trial lawyers instead is to invite other problems that neither policymakers nor their constituents need.

Tiger Joyce is president of the American Tort Reform Association in Washington, D.C.

NACDS letter offers Administration, Congress 4 policy solutions to curb opioid abuse

NACDS letter offers Administration, Congress 4 policy solutions to curb opioid abuse

http://www.drugstorenews.com/article/nacds-letter-offers-administration-congress–policy-solutions-curb-opioid-abuse

ARLINGTON, Va. — With President Donald Trump set to declare a national opioid emergency this week, the National Association of Chain Drug Stores has suggested four public policy initiatives to the Administration and members of Congress. The suggestions, outlined in a letter sent Tuesday, are aimed at building on current collaborative efforts to stem opioid abuse while maintaining high-quality patient care, NACDS said.

“These four integrated public policy strategies would further reduce the volume of unneeded and unused opioid medications entering the public domain, and reduce the chances that they fall into the wrong hands – while taking into account the needs of those most severely affected by chronic pain as a result of cancer and other serious illnesses,” NACDS president and CEO Steve Anderson said. “The fact that these public policy proposals are gaining traction among those in the healthcare and enforcement communities reflects that much-needed consensus may be starting to build for additional and sound approaches to this epidemic.”

Among the suggestions is a seven-day supply limit for initial opioid prescriptions issued for acute pain — a limit that is in-line with the Centers for Disease Control and Prevention’s Guideline for Prescribing Opioids for Chronic Pain. The letter notes that 20 states have already taken action on this issue, calling for federal legislation to ensure consistent care.

NACDS’ letter also calls for federal legislation mandating electronic prescribing for controlled substances — something that currently only happens for 14% of controlled substance prescriptions. Earlier this year, NACDS voiced its support for the Every Prescription Conveyed Securely Act, which was introduced in August.

The e-prescribing mandate would be one way to enhance security while curbing fraud, waste and abuse. It also would provide a foundation for improving security through a national prescription drug monitoring program that would harmonize varying state requirements for reporting and accessing PDMP data, creating a single system. A national PDMP would use e-prescribing to offer providers and dispensers real-time guidance for patients, NACDS said.

The organization also suggested the use of manufacturer-funded envelopes that patients could use to mail back unused opioids. The envelopes would be available at pharmacies upon request, and their use could be reinforced by a state-legislated mail-back program, NACDS said.

The letter also notes the need to regulate synthetic opioids, the importance of advancing prescriber education tools through the Food and Drug Administration’s Risk Evaluation and Mitigation Strategies for opioids and the need for enhanced treatment for patients with opioid abuse disorders, among other approaches.

“As public health authorities have indicated, face-to-face interactions between pharmacists and patients have made pharmacists keenly aware of the extreme challenges and complexities associated with this epidemic,” Anderson wrote in the letter. “Based on this first-hand experience and our commitment to the patients and communities we serve, NACDS remains steadfast in our efforts to partner with law enforcement agencies, policymakers, and others to work on viable strategies to prevent prescription drug diversion and abuse, including prescription opioids. Chain pharmacies engage daily in activities with the goal of preventing drug diversion and abuse.”

It would appear that the National Association of Chain Drug Stores is ON BOARD with all the various alphabet soup of federal agencies’ agenda on the opiate crisis.  Not one word in this letter about the “needs” of the chronic pain pts !

So what many pts who patronize chain drug stores have experienced in the past about not being able to get their controlled substance prescriptions filled and given a multitude of reasons/excuses why they can’t have their controlled substance prescription filled.

from the NACDS letter Chain pharmacies engage daily in activities with the goal of preventing drug diversion and abuse.”

So the fewer controlled prescriptions they fill …they will be reducing the potential of drug diversion and abuse… but.. that only applies to legal opiates… will not touch – maybe increase – the reported 100 million that the drug cartels sell “on the street” of ILLEGAL OPIATES.

Of course, the denial of a chronic pain pt’s legal prescriptions could force those pts to commit suicide or in desperation … turn to trying to get some relief and buying street drugs and risking an unintentional OD and if they survive, then they will be labeled as having a “opiate use disorder”.

There are options to the CHAIN DRUG STORE… there are some 21,000 – 22,000 independent pharmacies in this country and generally your copays will be the same as from the chains.  Unlike the chain employed Pharmacists, the Pharmacist of the owners is not guaranteed a paycheck every pay period regardless if they fill your legit/on time/medically necessary prescription(s) or not.

Many independents provide delivery home at no charge and must less likely to treat you like a addict/criminal and most are much better staffed… so the wait time to get a prescription filled is generally much shorter.

I had my own independent pharmacy for 20+ yrs… so I am very familiar with the concept and mindset of the Pharmacist/owner.

Generally independents can order medication Monday – Thursday and get it the next day… some may take a extra day. The drug wholesalers are rationing controls to all pharmacies … so that may come into play when they can get controls back into inventory.

If the independent is a little bit longer drive, talk to the pharmacist into “syncing your meds” …where they set it up that you get all your meds every month on the SAME DAY…  How many trips/month are you now making to get all your meds ? Take all your prescriptions to the independent… if the chain that you have been patronizing is only interested in filling your non-control prescriptions and not your controls… do they deserve to have any of your business ?

http://www.ncpanet.org/home/find-your-local-pharmacy    here is website link where you can find independent pharmacies by ZIP CODE.

 

ACLU: can find resources to defend ONE ILLEGAL ALIEN… chronic pain pts being denied care – NOT SO MUCH ?

Today, after a successful ACLU court case and persistent grassroots action, we helped achieve justice for Jane Doe, a 17-year-old-woman who came to the U.S. without her parents and is in a government-funded shelter. The Trump Administration did everything imaginable to force her to stay pregnant against her will.

This morning Jane was able to end her pregnancy safely and legally. It’s her decision – that’s still the law in this country.

We still have much work to do to overturn the outrageous policies at the heart of this issue and secure justice for ALL Janes. We know there are many more Janes out there: young women being held in federal custody who are being denied the ability to get abortion care and coerced and shamed for their decisions.

But, today, the most powerful words I can share with you are those of Jane herself. Here’s an excerpt from a statement she released earlier today through her guardian:

“No one should be shamed for making the right decision for themselves. I would not tell any other girl in my situation what they should do. That decision is hers and hers alone.

I’ve been waiting for more than a month since I made my decision. It has been very difficult to wait in the shelter for news that the judges in Washington, D.C. have given me permission to proceed with my decision. I am grateful for this, and I ask that the government accept it. Please stop delaying my decision any longer.

My lawyers have told me that people around the country have been calling and writing to show support for me. I am touched by this show of love from people I may never know and from a country I am just beginning to know – to all of you, thank you.

This is my life, my decision. I want a better future. I want justice.”

Thanks to everyone, especially the entire ACLU family and activists like you, who fought to give Jane the justice she deserves.

Keep fighting!

Brigitte Amiri
ACLU attorney, fighting for reproductive rights

P.S. There’s still time to add your name to our petition, which we’re delivering to the Health and Human Services Department tomorrow, calling on the Trump Administration to stop denying women their basic human rights. Click here to add your name to the petition.

DEA Blasted for Stonewalling Probe On Opioid Pill Dumping

DEA Blasted for Stonewalling Probe On Opioid Pill Dumping

As Trump declares a public health emergency, a congressional committee can’t squeeze answers out of the federal agency.

Even as President Donald Trump was preparing to declare the opioid crisis a public health emergency, a Republican congressman was criticizing the federal Drug Enforcement Agency for stonewalling an investigation to help solve the problem.

Rep. Greg Walden (R-Ore.) criticized the DEA for failure to cooperate with a congressional investigation into alleged opioid pill dumping by major drug companies in West Virginia. About 9 million hydrocodone pills were shipped over two years to a single pharmacy in a rural town of fewer than 400 people. The DEA has not yet released the identities of the companies suspected of supplying the pills.

“To me, this is a pretty basic question. Who are the suppliers?” Walden said.

Walden, who heads the House Energy and Commerce Committee, which is conducting the probe, threatened to issue a subpoena for the information “because we are done waiting.”

“I’m going to be very blunt: My patience is wearing thin. Our requests for data from the DEA are met with delay, excuses and, frankly, inadequate response,” Walden said as he opened a committee hearing Wednesday. “People are dying. Lives and families are ruined. It is time for DEA to get this committee the information we need, and to do it quickly. No more dodges. No more delays.”

He pointed out that opioid overdoses last year alone killed “more Americans than the entire Vietnam War.” In his state of Oregon, overdoses kill more people than car accidents. An estimated 91 lives are lost in the nation each day due to opioid overdoses.

Walden said the committee was still missing information requested from DEA back in May. DEA officials said they were “unaware” of some information, such as data concerning delayed or blocked enforcement action against drug companies, according to Walden. Yet the committee managed to obtain the information from an anonymous source. “Enough is enough,” said the irritated congressman.

 “Sir, we appreciate your concern and, absolutely, we are treating it with the utmost importance, as it should be treated,” DEA Deputy Assistant Administrator Neil Doherty told Walden at the hearing. “There is no reason for the extended delay of the questions. … We will make every effort to expedite every request that is outstanding.”

An investigation earlier this month by The Washington Post and “60 Minutes” revealed that Congress — pressed by pharmaceutical company lobbyists and wooed with campaign contributions — stripped the DEA last year of key crackdown tactics against companies whose drugs end up on the streets.

Trump had nominated Rep. Tom Marino (R-Pa.), a pivotal supporter of the DEA limits, to head the White House Office of National Drug Control Policy. But Marino withdrew his name from consideration after the Post report.

West Virginia counties have filed suit against drug companies and pharmacies, and other states are now taking similar action.

Many of the regions that backed Trump in last year’s election are being hit particularly hard by the opioid epidemic. On Thursday, the president stopped short of declaring the problem a national  emergency, which could have freed billions of dollars for the fight. His declaration of a public health emergency did not specifically release funds or name an amount to address the problem, but he is expected to ask for extra money to battle the crisis, The New York Times reported.

the value of a life… when damaged by MEDICAL ERRORS — NOT MUCH ??

http://www.sacbee.com/opinion/op-ed/soapbox/5h0qm0/picture180955361/alternates/LANDSCAPE_1140/GettyImages-200526677

Doctors said it was just a migraine – then a friend had to save my

life. Here’s why suing is pointless

http://www.sacbee.com/opinion/op-ed/soapbox/article180955366.html

It was midnight and I paced around my bedroom holding ice packs on my head. I realized, this is not normal.

I went to Sutter Medical Center emergency room in Sacramento. With tears running down my face, I told the doctor I had the worst headache of my life. I was given pain medication and sent home, diagnosed with a migraine. But I was actually in the early stages of an impending stroke.

I was only 45. I’ve worked in politics for over 20 years and at the time was the senior strategist for the California Democratic Party.

Fourteen hours later, I didn’t know my son’s name. A friend saved my life by taking me to the emergency room again. I don’t remember much for seven days. Family and friends came to my bedside. Doctors talked about making nursing home arrangements for me.

When doctors wanted to release me 10 days after I was admitted, I told them something wasn’t right. I had severe back pain for six days, and was coughing up blood. They said I should still leave. I accepted their diagnosis. Again.

  In less than two days, I was back in the emergency room. The pain was unbearable and I had lost vision on my left side. Turns out I had a previously undiagnosed pulmonary embolism, a large leg blood clot and now a brain hemorrhage. I had been right. Something was wrong. Again, they didn’t listen to me.

My story, later described in a suit, isn’t unique. A friend told her doctor that for two weeks, she had experienced the worst headache of her life, and asked if it could be a stroke. She was prescribed opioids. She had a major stroke that landed her, a 31-year-old dance teacher, in a walker, dependent on the pain meds. She eventually had to pay out of pocket for the treatment necessary to end her dependence.

A recent Johns Hopkins study showed medical errors are the third leading cause of death in the U.S., surpassed only by heart disease and cancer.

My friend and I face lifetime consequences from our strokes. But a 1975 California law supported by many of the lawmakers I have looked up to all but prevents us from suing for medical malpractice.

Under the Medical Injury Compensation Reform Act, damages for pain and suffering in a medical malpractice suit are capped at $250,000, and the maximum cap is typically only awarded in cases resulting in death.

So if a child is killed by a preventable medical error, his or her life is worth $250,000. Same goes for the elderly, or a stay-at-home mom or anyone else not making a salary that can be figured into the raw, unemotional math of “economic damages” in malpractice cases.

To put this in perspective, that $250,000 cap hasn’t changed one cent since 1975. In 1975, home prices averaged under $50,000, and the minimum wage was about $2 an hour.

If the malpractice law were adjusted for inflation, the law today would cap pain and suffering damages in personal injury cases at $1.3 million dollars. But the Medical Injury Compensation Reform Act doesn’t include a cost-of-living increase. So while court and expert witness costs rise each year, the award doesn’t.

Doctors say they fear that if the cap is raised their malpractice premiums will increase. I feel the same about my car insurance, but I pay it.

Because of my profession and my privilege, I was able to find a lawyer to take my case, though I dropped the suit when I realized that the aggravation of a drawn out court fight would hamper my healing. I also knew that any award would be much less than the $250,000 cap. And if I agreed to accept a settlement, I likely would have had to sign away my right to speak out. I believe it’s important to tell my story not only for myself, but for others.

I have advantages that come with an education and friendships with people in power. If I had been a farmworker, a minimum wage worker juggling two jobs, my access to justice would have been limited.

I am one of the lucky ones. I can read, write, walk and earn a living. But I carry with me anger that’s hard to let go. Medical errors are a difficult political and social issue to discuss. We all want to believe our doctor would never make a mistake that could alter our lives.

But doctors aren’t gods, even yours. They are human. And part of that humanity is making things right.

Medical errors devastate families, especially those that have few resources and don’t have a political voice in the halls of the Capitol. People working minimum wage, people of color, and women are the primary victims of this draconian law.

Our Legislature can choose to fix the Medical Injury Compensation Reform Act at any time by passing a bill and sending it to the governor to raise or remove the cap or just let juries decide.

This change would allow doctors to practice, knowing if an error happens, they have a path to make things right. And they can start to rebuild the trust of the patients who have been harmed.

Kolodny: 81 billion dollars/yr is not enough to fight the failed war on drugs

No new funding in Trump’s emergency opioid declaration

http://www.modernhealthcare.com/article/20171026/NEWS/171029906

Expectations the White House would make strides toward fighting the opioid epidemic fell short in the eyes of many when President Donald Trump on Thursday formally declared a public health emergency without calling for new funding to support treatment efforts.

Trump announced plans to direct Acting HHS Secretary Eric Hargan to declare the opioid crisis a national emergency under section 319 of the Public Health Service Act. Trump said the scale of the epidemic requires the aid of every federal agency and the resolve of every American.

“I want the American people to know that the federal government is aggressively fighting the opioid epidemic on all fronts,”Trump said.

As a first step, the administration planned to rescind a current Medicaid rule that limits how long patients can receive mental health or substance use disorder treatment in residential facilities with more than 16 beds. Currently the program covers the costs for up to 15 days.

“A number of states have reached out to us asking for relief and you should expect to see approvals that will unlock treatment for people in need and those approvals will come very, very fast,” Trump said.

But eliminating the rule would take an act of Congress while the CMS has provided state waivers for some years.

Overall the declaration was seen helping raise public awareness.

“We strongly support President Trump’s decision to officially label the opioid epidemic a public health emergency,” said Rep. David McKinley (R-WV) in an emailed statement. “As ground zero for this public health emergency, it is time West Virginia received the resources it deserves, and today’s action is a big step towards accomplishing that.”

“Really, he’s going to be asking the entire government to get behind this effort,” said Tom Coderre, senior adviser at the Altarum Institute and a former chief of staff and senior adviser to the Assistant Secretary at SAMHSA during the Obama administration. “That’s the bigger message of today, but certainly the devil is always in the details.”

The president of the American College of Physicians Dr. Jack Ende released a statement saying he was encouraged by Trump’s annoucement but pointed out the need for adequate funding. He said the Public Health Emergency Fund currently had only $57,000 as a result of Congress failing to replenish it for several years.

“Efforts need to be made to make substance use disorder treatment more accessible to those in under-served areas,” Ende said. ” We hope that today’s declaration will be used in a way that achieves that goal.”

Others were more critical and saw the declaration another disappointment.

Grant Smith, deputy director of national affairs for the Drug Policy Alliance in a written statement called the announcement “a drop in a bucket.” “We need a well thought out plan from the Trump administration that resolves the many obstacles people face trying to access medication-assisted treatment and naloxone to save lives.”

Baltimore City Health Commissioner Dr. Leana Wen questioned why a broader national emergency, under the Stafford Act, was not declared. That would have made billions in emergency funding available through FEMA’s Disaster Relief Fund.

“I looked to the president to commit a specific dollar amount from new funding rather than re-purposed dollars that take away from other key health priorities,” Wen said.

Under a public health emergency, HHS will allow states and counties greater flexibility in how federal funds are used. The agency will also seek to waive current rules that prohibit patients from receiving medication-assisted treatment through telemedicine in order expand access.

“That does have a potential to help reach patients who live in more rural areas,” said Cynthia Reilly, director of the Pew Charitable Trusts’ Substance Abuse Prevention and Treatment Initiative. “It [the declaration] could certainly help with that aspect of the problem.”

The order also makes the Department of Labor’s Dislocated Worker Grants—usually given to help those out of work due to natural disaster—available to help people who are unemployed because of addiction. At a meeting of Trump’s opioid commission held last week, Labor Secretary Alex Acosta testified that this was the “number one issue” in joblessness.

Trump’s declaration allows HHS to hire temporary personnel. The agency can also direct states upon its governor’s request to temporarily reassign state and local public health department personnel who receive federal funding to work on addressing opioid abuse during the emergency period.

Despite such changes, some addiction treatment experts feel the administration’s decision not to call for new funding within the emergency declaration confirms that the White House lacks direction on dealing with the crisis.

“They don’t have a plan,” said Dr. Andrew Kolodny, co-director of policy research at Brandeis University. “They rattled off a few items, but there’s no real plan.”

New DEA teams in six metro areas that will combat flow of heroin and fentanyl

The U.S. Drug Enforcement Administration said Friday it is forming teams in Cleveland and Cincinnati to combat the opioid epidemic by limiting the flow of drugs like heroin, shown here, and fentanyl.New DEA teams in Cleveland and Cincinnati will combat flow of heroin and fentanyl

http://www.cleveland.com/metro/index.ssf/2017/10/new_dea_teams_in_cleveland_and.html

CLEVELAND, Ohio – The U.S. Drug Enforcement Administration said Friday that it is forming new enforcement teams in new enforcement teams in Cleveland and Cincinnati that will focus on eradicating the flow of heroin and fentanyl.that will focus on eradicating the flow of heroin and fentanyl.

The two enforcement teams are among six that the agency is forming across the U.S. to combat an opioid epidemic that claimed roughly 34,500 lives last year. The other four enforcement teams will be in New Bedford, Massachusetts; Long Island, New York; Charleston, West Virginia; and Raleigh, North Carolina, the agency said in a news release.

The DEA chose the six locations by studying data related to opioid overdose deaths and heroin and fentanyl seizures. The teams’ investigations will not be limited to the geographic areas near those cities, the agency said.

“The DEA’s top priority is addressing the opioid epidemic and pursuing the criminal organizations that distribute their poison to our neighborhoods,” the agency’s acting administrator, Robert W. Patterson, said in a news release. “These teams will enhance DEA’s ability to combat trafficking in heroin, fentanyl, and fentanyl analogues and the violence associated with drug trafficking.”

The agency’s fiscal year 2017 budget includes funding to establish the teams, which will be comprised of DEA special agents and state and local task force officers. The teams are part of a broader DEA strategy that also includes enforcement against international and domestic drug trafficking organizations, the agency said.

The teams are being established at a time when drug overdoses are the leading cause of injury-related death in the U.S. Nearly 54 percent of the country’s 64,000 drug overdose deaths in 2016 were caused by opioids, Centers for Disease Control and Prevention statistics show. 

In Ohio, more than 4,050 people died of unintentional drug overdoses in 2016, with many of those being caused by opioids. In Cuyahoga County, heroin and fentanyl killed more people last year than homicides, suicides and car crashes.

Officials in Cuyahoga County and statewide have taken steps to curb the opioid epidemic by addressing prescription drug abuse, which experts say is inextricably linked to heroin and fentanyl abuse.

On Friday, Cuyahoga County Prosecutor Michael O’Malley announced that his office is filing a lawsuit that accuses several major prescription drug companies of intentionally misleading the public about the dangers of painkillers as they raked in “blockbuster profits.”

Cuyahoga County files lawsuit accusing drug companies of racketeering, leading to opioid epidemic

The lawsuit is similar to one Ohio Attorney General Mike DeWine filed over the summer against some of the same manufacturers.

Cuyahoga County officials are also urging residents to return unused and unnecessary prescription drugs Saturday during the annual Take Back Your Meds Day. The annual event, which is part of the DEA’s National Prescription Drug Take Back Day, will feature more than 40 locations where people can return prescription drugs throughout the county.

The DEA being in charge of the war on drugs for some 43 years… are just now deciding to focus on new enforcement teams in Cleveland and Cincinnati that will focus on eradicating the flow of heroin and fentanyl in just SIX METRO AREAS  Cleveland, Cincinnati, New Bedford, Massachusetts; Long Island, New York; Charleston, West Virginia; and Raleigh, North Carolina

It is reported that we are up to 81 billion/yr in expenditures on the war on drugs and closing in on TWO TRILLION dollars expended since the Control Substance Act was signed into law in 1970… which started with at 43 million/yr budget and 1200-1500 agents.

Collectively, has the DEA had their head stuck up their ass for the last 47 years ? We how have the highest per-cent of our population in jail/prison than any other major country. Mostly for minor non-violent drug offenses.

I am sure that most know by now that we have FOR-PROFIT PRIVATE PRISONS Corrections http://www.cca.com/  is a major player… that lobby Congress for longer sentences for non-violent offenders… so that they make a profit for “baby-sitting” these inmates.

The only “social war” that we have been dealing with longer than the war on drugs is the “war on poverty” that started in 1965 and we have spent some 15 TRILLION on.

Bright-Light Treatment Shows Promise for Fibromyalgia

Bright-Light Treatment Shows Promise for Fibromyalgia

https://www.medscape.com/viewarticle/881527

BOSTON — Morning bright-light treatment may be an effective adjunctive treatment for fibromyalgia, improving function and easing pain sensitivity, perhaps by shifting sleep patterns in a way that appears to help fibromyalgia, results of a pilot study suggest.

Helen J. Burgess, PhD, director, Biological Rhythms Research Laboratory and professor, Department of Behavioral Sciences, Rush University Medical Center in Chicago, Illinois, presented the study here at SLEEP 2017: 31st Annual Meeting of the Associated Professional Sleep Societies.

Morning light treatment has been shown to reduce depression. Moreover,  improved mood can lead to diminished pain and improvement in people’s ability to cope and function with pain.

Dr Burgess and colleagues tested the effect of bright-light treatment on function and pain sensitivity in 10 women meeting American College of Rheumatology 2010 criteria for fibromyalgia.

 

The women slept at home, keeping their usual sleep schedule for 1 week, followed by an overnight session in the sleep lab. During the overnight session, the researchers assessed baseline function (Fibromyalgia Impact Questionnaire [FIQ]), pain sensitivity (heat threshold and tolerance), and circadian timing (dim-light melatonin onset). 

The following morning, the women were randomly assigned to 6 days of a self-administered home morning (n = 6) or evening (n = 4) light treatment, using light boxes 1 hour per day. Afterward, function, pain sensitivity, and circadian timing were reassessed.

On average, the women completed 84% of the scheduled light treatments. No side effects were reported.

Both morning and evening light treatments led to improvements in function and pain sensitivity, but only morning light treatment led to a clinically meaningful improvement in function (>14% reduction in FIQ) and heat pain threshold (P < .05).

Dr Burgess noted that the improvement was about equal to that seen after cognitive-behavioral therapy and about half of that seen after weeks of intense exercise therapy. 

The study also found that phase advances in circadian timing were associated with an increase in pain tolerance (r = 0.67; P < .05).

Dr Burgess cautioned that more study is needed before light treatment can be used to manage chronic pain. “Our study sample was very small, and the results simply suggest that we keep investigating light treatment as a possible treatment to reduce pain and improve function,” she told Medscape Medical News.

“Noteworthy” Study

Approached for comment, Shelby Harris, PsyD, director, Behavioral Sleep Medicine, Sleep-Wake Disorders Center, Montefiore Health System, New York City, said this is a “very noteworthy and novel study since, in terms of helping sleep and fibromyalgia, the researched sleep treatments in this population — that we currently have on hand — are cognitive-behavior therapy for insomnia and medication interventions.”

 

“This study utilized a simple, quick method (light therapy) to help patients shift sleep patterns in a way that appears to help their fibromyalgia symptoms,” Dr Harris told Medscape Medical News.

 

“Patients with fibromyalgia typically suffer from difficulties falling asleep and staying asleep,” she said, “and this study noted that early-morning light exposure helped to advance their sleep timing, helping them to fall asleep earlier.”

 

“It is very possible that earlier sleep times, with less tossing and turning in bed throughout the night, can lead to more alertness in the morning, pain tolerance, helping to decrease pain and increase overall functioning. However, this was a small study and one that needs more research behind it,” added Dr Harris.

 

She also noted that some patients are “not ideal candidates for light boxes due to eye problems, and it would be interesting to see whether similar results would be found using natural outdoor light. This is worth studying further because a simple technique may make a big impact on the lives of those with chronic pain problems. More research is needed in this area,” said Dr Harris.

 

Kevin Fleming, MD, medical director of the Fibromyalgia and Chronic Fatigue Clinic at Mayo Clinic in Rochester, Minnesota, also thinks the study is noteworthy.

 

“Although a small study (just 10 patients) and only 1 week long, it is very suggestive of being useful because it fits with at least one physiology issue known to contribute to FM [fibromyalgia] — bad sleep. Light therapy may address that portion,” he told Medscape Medical News.

 

“Impaired sleep is known to be common in FM and likely contributes to pain (sleep deprivation makes people have widespread discomfort like FM),” Dr Fleming explained. “Why this is so is unclear; what sleep does for our muscles and brain is uncertain. But lacking good sleep contributes to pain, so it is reasonable to focus on sleep in treating FM.”

 

“The sleep clock (circadian rhythm) is set at least in part by your exposure to bright light, such as sunlight. Exposure to bright light or light therapy can remedy that part of the sleep disorder,” he noted.

 

Dr Fleming said light therapy for fibromyalgia is worth continued study. 

 

“There’d be no way to do a randomized trial I can think of, but size could be increased and compared to usual FM care for 12 months,” he said.